• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病合并肺结核患者血清炎症因子水平变化与疾病严重程度的相关性

Correlation Between Serum Inflammatory Factor Level Changes and Disease Severity in Patients with Chronic Obstructive Pulmonary Disease Complicated by Tuberculosis.

作者信息

Di Yiyao, Yang Fan, Che Conglu, Xu Shenghui, Qi Ying

机构信息

Respiratory Department, Affiliated Hospital of Hebei University, Baoding, Hebei, People's Republic of China.

Emergency Department II, Baoding First Central Hospital, Baoding, Hebei, People's Republic of China.

出版信息

Int J Gen Med. 2025 Jun 28;18:3547-3556. doi: 10.2147/IJGM.S522251. eCollection 2025.

DOI:10.2147/IJGM.S522251
PMID:40607012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12219164/
Abstract

BACKGROUND

The coexistence of chronic obstructive pulmonary disease (COPD) and tuberculosis (TB) complicates diagnosis and treatment, increasing disease burden and mortality. The correlation between serum inflammatory factors and disease severity and prognosis in COPD patients with TB remains unclear.

METHODS

This retrospective study included 200 participants treated at the Affiliated Hospital of Hebei University from December 2020 to December 2022: 80 patients with COPD and TB, 40 with COPD alone, 40 with TB alone, and 40 healthy controls. Serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interferon-γ (IFN-γ), soluble IL-2 receptor (sIL-2R), and C-reactive protein (CRP) were compared across groups and correlated with disease severity and prognosis in COPD patients with TB.

RESULTS

Serum levels of TNF-α, IL-6, IFN-γ, sIL-2R, and CRP were significantly higher in the COPD with TB group compared to all other groups (P<0.05). In this group, elevated levels of these markers were associated with increased disease severity and poorer prognosis (P<0.05). Correlation analysis showed positive associations between inflammatory cytokine levels and disease severity, and negative associations with prognosis (P<0.05).

CONCLUSION

Serum inflammatory markers may help assess disease severity and prognosis in COPD patients with TB. However, due to the observational design, causality cannot be inferred. Further prospective, multi-center studies are required to validate these findings before clinical application.

摘要

背景

慢性阻塞性肺疾病(COPD)与结核病(TB)并存会使诊断和治疗复杂化,增加疾病负担和死亡率。COPD合并TB患者血清炎症因子与疾病严重程度及预后的相关性尚不清楚。

方法

这项回顾性研究纳入了2020年12月至2022年12月在河北大学附属医院接受治疗的200名参与者:80例COPD合并TB患者、40例单纯COPD患者、40例单纯TB患者和40名健康对照者。比较各组血清肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、干扰素-γ(IFN-γ)、可溶性IL-2受体(sIL-2R)和C反应蛋白(CRP)水平,并分析其与COPD合并TB患者疾病严重程度和预后的相关性。

结果

与所有其他组相比,COPD合并TB组的血清TNF-α、IL-6、IFN-γ、sIL-2R和CRP水平显著更高(P<0.05)。在该组中,这些标志物水平升高与疾病严重程度增加和预后较差相关(P<0.05)。相关性分析显示炎症细胞因子水平与疾病严重程度呈正相关,与预后呈负相关(P<0.05)。

结论

血清炎症标志物可能有助于评估COPD合并TB患者的疾病严重程度和预后。然而,由于本研究为观察性设计,无法推断因果关系。在临床应用之前需要进一步的前瞻性、多中心研究来验证这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09d/12219164/9f82370efdd1/IJGM-18-3547-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09d/12219164/e62102c9c7c2/IJGM-18-3547-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09d/12219164/e250ea8e34f0/IJGM-18-3547-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09d/12219164/a74939937179/IJGM-18-3547-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09d/12219164/9f82370efdd1/IJGM-18-3547-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09d/12219164/e62102c9c7c2/IJGM-18-3547-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09d/12219164/e250ea8e34f0/IJGM-18-3547-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09d/12219164/a74939937179/IJGM-18-3547-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09d/12219164/9f82370efdd1/IJGM-18-3547-g0004.jpg

相似文献

1
Correlation Between Serum Inflammatory Factor Level Changes and Disease Severity in Patients with Chronic Obstructive Pulmonary Disease Complicated by Tuberculosis.慢性阻塞性肺疾病合并肺结核患者血清炎症因子水平变化与疾病严重程度的相关性
Int J Gen Med. 2025 Jun 28;18:3547-3556. doi: 10.2147/IJGM.S522251. eCollection 2025.
2
Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis.精神分裂症急性和慢性期外周细胞因子及相关炎症蛋白浓度的变化模式:一项系统评价和网状Meta分析
Lancet Psychiatry. 2023 Apr;10(4):260-271. doi: 10.1016/S2215-0366(23)00025-1. Epub 2023 Feb 27.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
4
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.噻托溴铵与长效β受体激动剂治疗稳定期慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009157. doi: 10.1002/14651858.CD009157.pub2.
5
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).远程医疗干预:针对慢性阻塞性肺疾病(COPD)患者的远程监测和咨询。
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Central Inflammatory Cytokines in Tuberculous Meningitis: A Systematic Review and Meta-analysis.结核性脑膜炎中的中枢炎症细胞因子:系统评价与荟萃分析
J Interferon Cytokine Res. 2022 Mar;42(3):95-107. doi: 10.1089/jir.2021.0176.
9
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.
10
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.

本文引用的文献

1
Effect of different doses of Budesonide combined with Tiotropium bromide inhalation on elderly patients with chronic obstructive pulmonary disease.不同剂量布地奈德联合噻托溴铵吸入对老年慢性阻塞性肺疾病患者的影响
Pak J Med Sci. 2024 Aug;40(7):1338-1344. doi: 10.12669/pjms.40.7.9209.
2
The effect of budesonide combined with bifidobacteria and lactobacilli on lung function and gut microbiota of patients with chronic obstructive pulmonary disease.布地奈德联合双歧杆菌和乳酸杆菌对慢性阻塞性肺疾病患者肺功能和肠道微生物群的影响
Pak J Med Sci. 2024 Mar-Apr;40(4):695-700. doi: 10.12669/pjms.40.4.8514.
3
Characteristics of Serum Autoantibody Repertoire and Immune Subgroup Variation of Tuberculosis-Associated Obstructive Pulmonary Disease.
血清自身抗体谱特征与结核相关阻塞性肺病免疫亚群变化。
Int J Chron Obstruct Pulmon Dis. 2023 Dec 5;18:2867-2886. doi: 10.2147/COPD.S434601. eCollection 2023.
4
Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases.肺结核后慢性阻塞性肺疾病的负担、临床特征和结局。
Curr Opin Pulm Med. 2024 Mar 1;30(2):156-166. doi: 10.1097/MCP.0000000000001026. Epub 2023 Oct 30.
5
Post-tuberculosis lung disease and chronic obstructive pulmonary disease.肺结核后肺部疾病和慢性阻塞性肺疾病。
Chin Med J (Engl). 2023 Aug 20;136(16):1923-1928. doi: 10.1097/CM9.0000000000002771. Epub 2023 Jul 14.
6
Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease.肺结核导致肺损伤的机制:对慢性阻塞性肺疾病的影响。
Front Cell Infect Microbiol. 2023 Jun 21;13:1146571. doi: 10.3389/fcimb.2023.1146571. eCollection 2023.
7
Small airways obstruction and its risk factors in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional study.在负担性阻塞性肺病(BOLD)研究中,小气道阻塞及其危险因素:一项多国横断面研究。
Lancet Glob Health. 2023 Jan;11(1):e69-e82. doi: 10.1016/S2214-109X(22)00456-9.
8
Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年慢性阻塞性肺疾病负担及其可归因危险因素:2019 年全球疾病负担研究结果。
BMJ. 2022 Jul 27;378:e069679. doi: 10.1136/bmj-2021-069679.
9
Inflammasome Contribution to the Activation of Th1, Th2, and Th17 Immune Responses.炎性小体对Th1、Th2和Th17免疫反应激活的作用。
Front Microbiol. 2022 Mar 17;13:851835. doi: 10.3389/fmicb.2022.851835. eCollection 2022.
10
The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection.IGRA在结核病感染诊断、与活动性结核病鉴别以及对结核病感染启动治疗或预防性治疗的决策中的作用。
Int J Infect Dis. 2022 Nov;124 Suppl 1:S12-S19. doi: 10.1016/j.ijid.2022.02.047. Epub 2022 Mar 5.